Patrick Born

Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma

Nico Gagelmann, Danai Dima, Maximilian Merz et al. · Journal of Clinical Oncology · 2024 · 83 citations · Full text

Medicine, Immunology, Oncology +17

Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma

Luise Fischer, Nora Grieb, Patrick Born et al. · Leukemia · 2024 · 65 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma

Michael Rade, Nora Grieb, Luise Fischer et al. · Nature Cancer · 2024 · 58 citations

Medicine, Immunology, Oncology +16

Bispecific Antibodies as Bridging to BCMA CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma

David Fandrei, Sabine Seiffert, Michael Rade et al. · Blood Cancer Discovery · 2024 · 42 citations · Full text

Life Sciences, Hematology, Immunology +15

Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study

Maximilian Merz, Anca‐Maria Albici, Bastian von Tresckow et al. · HemaSphere · 2025 · 38 citations · Full text

Pharmacy, Oncology, Pharmacology +13